DEMANT vs NVO: Side-by-Side Comparison
Compare Demant A/S (DEMANT) and Novo Nordisk (NVO) side by side: market cap DKK 58.88B vs USD 223.40B, P/E 24.9 vs 11.8. Financials, growth and model signals on Bullrun.
| Metric | DEMANT | NVO |
|---|---|---|
| Company | Demant A/S | Novo Nordisk |
| Country / Exchange | Denmark · CO | Denmark · NYSE |
| Sector | Healthcare | Healthcare |
| Industry | Medical Devices | Drug Manufacturers-General |
| Market cap | DKK 58.88B | USD 223.40B |
| P/E ratio | 24.9 | 11.8 |
| Dividend yield | — | 2.53% |
| Valuation model | — | 23.4% undervalued |
| Revenue (latest FY) | DKK 22.97B | — |
| Revenue growth YoY | +2.5% | — |
| Net income | DKK 1.55B | — |
| Gross margin | 75.6% | — |
| Diluted EPS | 7.31 | — |